Navigation Links
PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
Date:9/23/2013

London (PRWEB) September 23, 2013

PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022

Summary

GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified as chronic, accelerated or blast phase, ranging from least to most severe. Multiple BCR-ABL tyrosine kinase inhibitors (TKIs) are approved, and are the standard of care for CML. TKIs have transformed most cases of the disease into a manageable, chronic condition. As a result, patients’ survival rates and the prevalence of CML are increasing, placing a growing burden on global healthcare systems

The UK has the second lowest prevalence of CML, and is currently the smallest CML market of the 7MM. Although an increasing prevalence of CML and the launch of Bosulif and Iclusig will act as driving forces of market growth, it will not be enough to compensate for erosion of Gleevec and Sprycel sales once their generic equivalents hit the market.

Scope

-Overview of the CML including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
-Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.
-Sales forecast for the top drugs in the UK from 2012-2022.
-Analysis of the impact of key events as well the drivers and restraints affecting the UK CML market.

Reasons to buy

-Understand and capitalize by identifying products that are most likely to ensure a robust return
-Stay ahead of the competition by understanding the changing competitive lands
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players
2. PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
4. Chronic aggressive behavior in boys: Epigenetic sources?
5. Rosacea Control by Forces of Nature Offers Brand-New Solution to Treat Chronic Skin Condition
6. CWRU researchers find what stresses parents with a chronically ill child
7. Predicting who will have chronic pain
8. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
9. Chronic Kidney Disease Market: 81M CKD Cases by 2022 Says a New Research Report at ReportsnReports.com
10. Chronic Fatigue Treatment
11. How “End Tiredness Program” Helps People Get Rid Of Tiredness – Vinamy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 (HealthDay News) -- Traveling through the same U.S. ... to three others within a four-hour time span, illustrating ... report shows. "The exposures in this report were ... an international terminal, highlighting the fact that measles is ... an infectious disease specialist at the U.S. Centers for ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 While countless companies ... do not realize the potential dangers of their purchase. Not ... prescription from a qualified doctor, but patients who buy hCG ... point that there is actually no real hCG present. Illegal ... where there are no safety standards and may contain unknown ...
(Date:12/17/2014)... Providence, RI (PRWEB) December 17, 2014 ... nationally recognize private practices that have made outstanding ... and in support and progression of private practice ... the American Physical Therapy Association. , On behalf ... DPT, OCS, owner and CEO of Performance accepted ...
(Date:12/17/2014)... WI (PRWEB) December 17, 2014 In ... Administrators and its Argus Claim Review division have ... of the most common ways savings are achieved on ... (TPA) attributes millions of dollars in savings to Argus ... in 2013. , As explained by Tom Doney, Cypress ...
(Date:12/17/2014)... Project Veritas is releasing a video ... MIT economist and Obamacare architect Jonathan Gruber to public ... the interview, which is being distributed on YouTube. , ... mislabeling in the Affordable Care Act in order to ... billion dollar per year tax grab. , “President Obama ...
Breaking Medicine News(10 mins):Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
... Yosef Shiloh, Ph.D., a David and Inez Myers professor ... genetics and biochemistry in the Sackler School of Medicine ... Annual AACR G.H.A. Clowes Memorial Award for his studies ... genomic instability syndrome ataxia-telangiectasia (A-T). "Dr. Shiloh is ...
... that a novel form of personalized therapy that ... to fight tumors could treat metastatic melanoma and ... therapeutic approach against these and other cancers. ... body,s immune system to fight cancer. Immune cells, ...
... , MONDAY, Jan. 31 (HealthDay News) -- Two new studies ... cancer: melanoma, a deadly malignancy that first appears in the ... The first study, appearing in the Jan. 31 issue ... engineered immune cells from the patient to fight off the ...
... , MONDAY, Jan. 31 (HealthDay News) -- Daytime ... improves greatly after surgery for the disorder, according to a ... partially or completely blocked in short spurts, causing pauses in ... occur 30 times or more an hour, disrupting sleep. The ...
... stem cells in the gut relieves a potentially lethal complication ... published online on January 31 in the Journal of ... can cure diseases such as leukemia but it can also ... (GVHD). A group led by Takanori Teshima at Kyushu ...
... American Chemical Society (ACS) today launched the inaugural edition of ... online snapshot of the countless ways in which chemistry improves ... special video welcome from Nancy B. Jackson, Ph.D., who serves ... Sandia National Laboratories in New Mexico. Every month through ...
Cached Medicine News:Health News:Yosef Shiloh, Ph.D., receives the 51st Annual AACR G.H.A. Clowes Memorial Award 2Health News:Yosef Shiloh, Ph.D., receives the 51st Annual AACR G.H.A. Clowes Memorial Award 3Health News:Novel immune system-based gene therapy induces strong responses in metastatic melanoma, sarcoma 2Health News:New Therapies Offer Insight Into Battling Deadly Melanomas 2Health News:New Therapies Offer Insight Into Battling Deadly Melanomas 3Health News:Drowsiness May Decline After Apnea Surgery 2Health News:American Chemical Society unveils International Year of Chemistry virtual journal 2Health News:American Chemical Society unveils International Year of Chemistry virtual journal 3
(Date:12/17/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or the ... $125 million aggregate principal amount of 3.75% Convertible Senior ... and sold only to qualified institutional buyers pursuant to ... amended (the "Securities Act"). The Notes bear ... payable semiannually in arrears on June 15 and December ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, ... (CTMC), and Integrated Clinical Trial Services, LLC (ICTS), ... for clinical trials announce that they have formed ... Services (i-CTMS). i-CTMS will provide a broad range ... biotechnology and medical device companies. i-CTMS ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind ... Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ ... zu besuchen. Diese Tagung soll ... die Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... COLUMBUS, Ohio, Jan. 8 IntelligentMDx a developer and ... that verification studies of the IntelligentMDx BK Viral ... the Limit of Detection, linearity, specificity and reproducibility ... were determined. The data obtain agreed with internally ...
... have identified mutations in a gene that predict a high ... Although the researchers caution that further research is needed to ... or IKAROS, lead to leukemia relapse, the findings ... to assess the risk of treatment failure. By using a ...
Cached Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6
... VISION is Guidant's first cobalt chromium stent ... MINI VISION to have remarkably thin struts ... creating a highly deliverable stent. Less metal, ... outcomes in small vessel treatment. The Guidant ...
... IRIS Medical IQ 810 infrared diode ... retinal disorders and glaucoma. The Companys ... technological innovation and is designed to ... (MIP) procedures in the office and ...
... early is best corrected with GP lenses. ... be present, GP lenses will help the ... will neutralize the distortions of the corneal ... is a fitting challenge for even the ...
... "a quantum leap forward in the evolution of ... Rose K lens has become the world's most ... keratoconus.,Unlike traditional contact lenses, the complex geometry built ... the cone like shape of the cornea, for ...
Medicine Products: